---
title: "editorial hiv prep"
year: 2023
month: 09
journal: "American Family Physician"
volume: "108"
issue: "09"
pages: ""
doi: ""
pmid: ""
source: "PDF Extraction"
pdf_available: true
original_pdf: "2023-09-editorial-hiv-prep.pdf"
extracted_date: "2025-08-10"
keywords: []
evidence_level: ""
clinical_significance: ""
---

# editorial hiv prep

                                                                Editorials
     Implementing HIV PrEP in Routine Practice
               Jarrett Sell, MD, FAAFP, AAHIVS, Penn State Health Hershey Medical Center, Hershey, Pennsylvania


            HIV continues to have an impact globally. An                         studies show that patients bring up PrEP more
            estimated 1.2 million people in the United States                    often than their physicians.7-9 This may be due to
            are living with HIV, and there are 38,000 new                        the physician’s lack of knowledge, discomfort, or
            cases of HIV each year, which has not decreased                      biases regarding sexual practices and terminol-
            in the past decade.1 This is despite the U.S. Food                   ogy, and may be mitigated by a self-assessment to
            and Drug Administration’s approval of oral                           identify specific knowledge deficits and implicit
            tenofovir/emtricitabine (Truvada) in 2012 for pre-                   biases and training on current sexual terminiol-
            exposure prophylaxis (PrEP). It has been shown to                    ogy.6 The sexual history of older and established
            be highly effective for preventing HIV acquisition,                  patients, in particular, is more likely to not be
            with an overall relative risk of 0.46 compared with                  consistently obtained or updated.7 Routinely ask-
            placebo and a lower relative risk of 0.27 in those                   ing brief, nonjudgmental, open-ended questions
            with 70% or greater adherence.2 Accordingly, the                     can help normalize inclusion of this important
            U.S. Preventive Services Task Force (USPSTF)                         aspect of health.
            recommends that physicians offer PrEP to people                        Access to physicians who prescribe PrEP, the
            at high risk of HIV acquisition (grade A recom-                      need for frequent visits, and cost can be signifi-
            mendation).2,3 Recent approval of oral tenofo-                       cant barriers to PrEP.10 Fortunately, the USPSTF
            vir alafenamide/emtricitabine (Descovy) and                          grade A recommendation necessitates insurance
            injectable cabotegravir (Apretude) has expanded                      coverage of medication costs and associated lab-
            options for HIV prevention.                                          oratory testing and clinical services. The Centers
               The Centers for Disease Control and Prevention                    for Disease Control and Prevention also pro-
            estimates that only 25% of the 1.2 million people                    vides resources for those who are uninsured or
            who could have benefited from PrEP received it in                    underinsured.11
            2020.4 The 2019 initiative, Ending the HIV Epi-                        Since the FDA approval of PrEP medications, a
            demic:​A Plan for America, set a goal of reduc-                      number of excellent resources on safe PrEP pre-
            ing new infections in the United States by at least                  scribing have been produced, including articles in
            90% by 2030;​PrEP use by 50% of those at risk is                     American Family Physician.3,12-18 In a recent sur-
            a key component of this plan.1 Yet, prescribing                      vey of 134 primary care physicians, respondents
            rates remain low and are not adequately reach-                       self-reported high overall knowledge of PrEP, and
            ing populations at the greatest risk of HIV acqui-                   most thought it was safe and effective.9 However,
            sition. Although Black and Hispanic patients                         respondents reported that they had less specific
            are disproportionately affected by HIV, they are                     knowledge of adverse effects, baseline laboratory
            less likely to be aware of or take PrEP compared                     testing, and ongoing laboratory safety monitor-
            with White men who have sex with men.5 Fam-                          ing, which are key pieces and potential barriers to
            ily physicians are ideally positioned to prevent                     PrEP implementation.
            HIV, improve access to PrEP, and address current                       It is time to move beyond training and
            health inequities.                                                   resources that focus solely on physician attitudes
               One of the first steps in understanding the                       and knowledge and design system-level solutions
            health needs of our patients is routinely asking                     to current inefficiencies and inequities in deliv-
            for a detailed sexual history that is open and                       ery of care. Potential solutions include electronic
            affirming.6 These conversations are opportunities                    health record (EHR) tools, local champions, and
            to eliminate inaccurate assumptions about HIV                        community resources.
            transmission risk and combat continued stigma                          A recent study showed that an EHR order set
            related to HIV, intravenous drug use, and various                    was the most important facilitator for PrEP pre-
            sexual practices. However, despite patients indi-                    scribing, and another study showed an increase in
            cating a preference for their physicians to rou-                     PrEP prescribing in primary care when an EHR
            tinely initiate conversations about sexual health,                   template was combined with education.9,19 Because

 Downloaded
September   from◆ the
          2023        American
                   Volume  108,Family
                                NumberPhysician
                                          3 website at www.aafp.org/afp.        © 2023 American Academy of American
                                                                         Copyright
                                                          www.aafp.org/afp                                              Family
                                                                                                            Family Physicians.     the private, 227
                                                                                                                               ForPhysician     non-
commercial use of one individual user of the website. All other rights reserved. Contact copyrights@aafp.org for copyright questions and/or permission requests.
                                                                 EDITORIALS


          family physicians do not have enough hours in the                    (preliminary data):​National HIV Surveillance System data
                                                                               reported through June 2021;​and preexposure prophylaxis
          day to address all the recommended preventive                        (PrEP) data reported through March 2021. HIV Surveil-
          health services with patients, EHR templates and                     lance Data Tables. 2021;​2(4):​1-28. Accessed July 22, 2023.
          order sets can streamline guideline-based care                       https://​w ww.cdc.gov/hiv/pdf/library/reports/surveillance-
                                                                               data-tables/vol-2-no-4/cdc-hiv-surveillance-tables-vol-
          and promote patient adherence and retention.20                       2-no-4.pdf
          Improved access to physician champions who                         5. Kanny D, Jeffries WL IV, Chapin-Bardales J, et al.;​National
          guide PrEP initiation and handle more complex                         HIV Behavioral Surveillance Study Group. Racial/ethnic
          management and clinical pharmacists who track                         disparities in HIV preexposure prophylaxis among men
                                                                                who have sex with men—23 urban areas, 2017. MMWR
          medication adherence and assist with medication                       Morb Mortal Wkly Rep. 2019;​68(37):​801-806.
          counseling has also been proposed.9 In addition,                  6. Savoy M, O’Gurek D, Brown-James A. Sexual health his-
          identifying and collaborating with local organiza-                   tory:​techniques and tips. Am Fam Physician. 2020;​101(5):​
          tions (e.g., LGBTQ+ centers, sexually transmitted                    286-293.
                                                                             7. Ryan KL, Arbuckle-Bernstein V, Smith G, et al. Let’s talk
          infection testing sites, addiction treatment centers,                 about sex:​a survey of patients’ preferences when address-
          after-school programs) that serve at-risk popula-                     ing sexual health concerns in a family medicine residency
          tions who do not routinely seek traditional med-                      program office. Primer. 2018;​2:​23.
          ical services is key to addressing health inequity.               8. Skolnik AA, Bokhour BG, Gifford AL, et al. Roadblocks to
                                                                               PrEP:​what medical records reveal about access to HIV
             As we strive to end the HIV epidemic and                          pre-exposure prophylaxis. J Gen Intern Med. 2020;​35(3):​
          implement the USPSTF recommendation to offer                         832-838.
          PrEP to all people who are at high risk of HIV                     9. Sell J, Chen R, Huber C, et al. Primary care provider HIV
                                                                                PrEP knowledge, attitudes, and prescribing habits:​a cross-
          acquisition, family physicians should consider                        sectional survey of late adopters in rural and suburban
          how patients can best initiate and adhere to treat-                   practice. J Prim Care Community Health. 2023;​14:​215​013​
          ment. Once PrEP is started, we can anticipate                         1​9​2​21147254.
          barriers to adherence. For example, scheduled                     10. Bonacci RA, Van Handel M, Huggins R, et al. Estimated
                                                                                uncovered costs for HIV preexposure prophylaxis in the
          office visits in a busy physician practice may not                    US, 2018. Health Aff (Millwood). 2023;​42(4):​5 46-555.
          be the preferred way to get laboratory tests and                  11. Centers for Disease Control and Prevention. Paying for
          medication refills, particularly for young, healthy                   PrEP. Accessed February 15, 2023. https://​w ww.cdc.gov/
          patients. At the first visit, it can be helpful to                    hiv/basics/prep/paying-for-prep/
                                                                            12. Gandhi RT, Bedimo R, Hoy JF, et al. Antiretroviral drugs for
          review local testing options, consider standing                       treatment and prevention of HIV infection in adults:​2022
          laboratory orders, determine frequency of office                      recommendations of the International Antiviral Society-
          visits, and discuss the ways that patients can                        USA Panel. JAMA. 2023;​329(1):​63-84.
          best communicate barriers to care or obtaining                    13. Centers for Disease Control and Prevention. US Public
                                                                                Health Service. preexposure prophylaxis for the preven-
          refills. What feasible, systems-based solutions                       tion of HIV infection in the United States—2021 update:​
          might make a difference in your area to promote a                     a clinical practice guideline. Accessed February 6, 2023.
          patient-centered approach for the prevention and                      https:// ​ w ww.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-
                                                                                guidelines-2021.pdf
          eradication of HIV?                                               14. Centers for Disease Control and Prevention. HIV Nexus clini-
          Address correspondence to Jarrett Sell, MD, FAAFP,                    cian resources. HIV prevention. Accessed February 6, 2023.
          AAHIVS, at jsell@​pennstatehealth.psu.edu. Reprints                   https://​w ww.cdc.gov/hiv/clinicians/prevention/index.html
          are not available from the author.                                15. American Academy of HIV Medicine. PrEP guidelines and
                                                                                recommendations. Accessed February 6, 2023. https://​
          Author disclosure:​No relevant financial relationships.               education.aahivm.org/product_bundles/2470
                                                                            16. National Clinician Consultation Center. PrEP:​pre-
          References                                                            exposure prophylaxis. Accessed February 14, 2023. https://​
           1. Harris NS, Johnson AS, Huang YA, et al. Vital signs:​status       nccc.ucsf.edu/clinician-consultation/prep- ​pre-​exposure-
              of human immunodeficiency virus testing, viral suppres-           prophylaxis/
              sion, and HIV preexposure prophylaxis—United States,          17. Tracer H, Jasmin W. Screening for HIV infection and preex-
              2013-2018. MMWR Morb Mortal Wkly Rep. 2019;​68(48):​              posure prophylaxis for the prevention of HIV infection. Am
              1117-1123.                                                        Fam Physician. 2019;​100(10):​637-638.
          2. Chou R, Evans C, Hoverman A, et al. Preexposure prophy-        18. Kaufman B, Zehtabchi S. Tenofovir for prevention of HIV
             laxis for the prevention of HIV infection:​evidence report         infection. Am Fam Physician. 2017;​96(1):​online. Accessed
             and systematic review for the US Preventive Services Task          July 22, 2023. https://​w ww.aafp.org/pubs/afp/issues/​2017/​
             Force. JAMA. 2019;​321(22):​2214-2230.                             0701/od1.html
          3. Preexposure prophylaxis for the prevention of HIV infec-       19. Lumsden J, Dave AJ, Johnson C, et al. Improving access
             tion:​recommendation statement. Am Fam Physician.                  to pre-exposure prophylaxis for HIV prescribing in a pri-
             2019;​100(10):​
                           online. Accessed July 22, 2023. https://​            mary care setting. BMJ Open Qual. 2022;​1 1(2):​e001749.
             www.aafp.org/pubs/afp/issues/2019/1115/od1.html                20. Porter J, Boyd C, Skandari MR, et al. Revisiting the time
          4. Centers for Disease Control and Prevention. Core indica-           needed to provide adult primary care. J Gen Intern Med.
             tors for monitoring the ending the HIV Epidemic Initiative         2023;​38(1):​147-155. ■


228 American Family Physician                                www.aafp.org/afp                              Volume 108, Number 3 ◆ September 2023
